Analytical Overview: Altimmune Inc (ALT)’s Ratios Tell a Financial Story

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Altimmune Inc’s stock clocked out at $8.43, down -1.63% from its previous closing price of $8.57. In other words, the price has decreased by -$1.63 from its previous closing price. On the day, 2.12 million shares were traded. ALT stock price reached its highest trading level at $9.23 during the session, while it also had its lowest trading level at $8.39.

Ratios:

To gain a deeper understanding of ALT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.87 and its Current Ratio is at 16.87. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on November 12, 2024, initiated with a Buy rating and assigned the stock a target price of $26.

On January 24, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $13.Goldman initiated its Neutral rating on January 24, 2024, with a $13 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 19 ’24 when Drutz David sold 16,011 shares for $6.90 per share. The transaction valued at 110,547 led to the insider holds 41,958 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALT now has a Market Capitalization of 599580416 and an Enterprise Value of 461973600. For the stock, the TTM Price-to-Sale (P/S) ratio is 11991.65 while its Price-to-Book (P/B) ratio in mrq is 4.50. Its current Enterprise Value per Revenue stands at 8884.107 whereas that against EBITDA is -4.657.

Stock Price History:

Over the past 52 weeks, ALT has reached a high of $14.84, while it has fallen to a 52-week low of $2.76. The 50-Day Moving Average of the stock is 18.01%, while the 200-Day Moving Average is calculated to be 11.52%.

Shares Statistics:

It appears that ALT traded 2.72M shares on average per day over the past three months and 6026840 shares per day over the past ten days. A total of 70.68M shares are outstanding, with a floating share count of 70.53M. Insiders hold about 0.83% of the company’s shares, while institutions hold 56.16% stake in the company. Shares short for ALT as of 1731628800 were 22836787 with a Short Ratio of 8.42, compared to 1728950400 on 22234476. Therefore, it implies a Short% of Shares Outstanding of 22836787 and a Short% of Float of 32.189997999999996.

Most Popular